Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Maintenance Study of Sodium Zirconium Cyclosilicate in Japanese Patients With Hyperkalemia
jRCT2080223573Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2017
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of sodium zirconium cyclosilicate in hyperkalemia, sponsored by AstraZeneca. Started Jun 2017; status: completed.
02
Drugs
sodium zirconium cyclosilicate
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on jRCT2080223573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223573.